Caredx Correlations

CDNA Stock  USD 21.44  0.62  2.81%   
The current 90-days correlation between Caredx Inc and Castle Biosciences is 0.22 (i.e., Modest diversification). The correlation of Caredx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Caredx Correlation With Market

Significant diversification

The correlation between Caredx Inc and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Caredx Inc and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caredx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Moving against Caredx Stock

  0.37DRUG Bright Minds BiosciencesPairCorr
  0.37CDIOW Cardio DiagnosticsPairCorr
  0.32VRNA Verona Pharma PLCPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
GHNTRA
MYGNCSTL
EXASMYGN
ILMNCSTL
MYGNBDSX
EXASBDSX
  
High negative correlations   
MYGNGH
MYGNNTRA
GHBDSX
EXASGH
NTRACSTL
NTRABDSX

Risk-Adjusted Indicators

There is a big difference between Caredx Stock performing well and Caredx Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Caredx's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Caredx Corporate Management

GS JhaChief VPProfile
Marco SchellerSenior OperationsProfile
Ian CooneyVice RelationsProfile
Jessica MengChief OfficerProfile
Jeffrey NovackGeneral SecretaryProfile
Hal GibsonSenior PlanningProfile